Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
Come and meet us at the following events:
254th ACS National Meeting & Exposition, 20th-24th August, Washington, DC, USA
We will be giving a talk entitled, “Employing microbial biocatalysis to deliver scalable amounts of metabolites for identification and biological evaluation“
International Isotope Society Central European Division Workshop, 7th-8th September, Bad Soden, Germany
21st North American ISSX Meeting, 24th-28th September 2017, Providence, Rhode Island, USA
Download a copy of our brochure on drug metabolites and C-H activated derivatives
Our new brochure on drug metabolites and C-H activated derivatives is now available. Inside we feature interesting case studies and client projects, including the following topics:
- Phase l CYP and non-CYP metabolites
- Phase ll conjugated metabolites
- Isotopically labelled metabolites
- Lead diversification and late stage functionalization
- Polar / C-H activated derivatives
Download a copy of our latest newsletter
In our latest newsletter we look at scalable mechanisms for obtaining the major circulatory and excretory conjugative metabolites of the drug lorcaserin.